Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures
← catalyst calendarNCT07530497 · readout ≤ 559 d
Sponsored by SI-BONE, Inc. (industry) · SIBN — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
120estimated
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Aug 2026 | estimated | When the study began enrolling |
| Primary completion | Feb 2028 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Aug 2028 | estimated | The whole study's end, after follow-up |
| First posted | 2026-04-15 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-08-07 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Fracture; Pelvic
- Insufficiency Fractures
- Fragility Fracture
- Sacroiliac; Fusion
- Sacroiliac Joint Disruption
- Sacroiliac Joint Dysfunction
Intervention
- Device: iFuse TORQ TNT Implant System
Primary outcome
what the primary-completion date above is the date OFComposite Measure
measured 6-months
Permalink · SIBN's whole pipeline · Catalyst calendar · Every registered study · What changed